Producing quality products that improve health
From the moment research and development begins to the time our medicines reach patients, Teva’s commitment to quality is uncompromising
Teva's extensive global operations network includes approximately 25,000 employees at more than 65 manufacturing sites in over 30 countries. 01
Here in the UK, we have invested in our manufacturing capabilites over the last decade.
- In Runcorn, Cheshire, we have a manufacturing facility for sterile liquid products used in the treatment of respiratory conditions, as well as multiple sclerosis and migraine, which are distributed to countries around the world.
- It’s also home to two research and development centres, developing sterile drug products and sterile device technology.
- In Northern Ireland, we have manufacturing and research facilities in Larne, focussing on hormonal rings, implants and intrauterine devices.
We strive to deliver quality generic and specialty medicines to different markets - quickly and effectively. The team that makes this happen spans several areas of our business including Research & Development, Quality Assurance, Regulatory Affairs, scientific and logistical support, customer service, marketing and sales.
Join Hikky, Paul and Amy as they take us behind the scenes and show us some of the quality and safety checks that goes in to producing medicines at our factory in Runcorn, UK. The site produces over 480 million doses of sterile medicine every year. That’s a lot of responsibility when it comes to keeping patients and our colleagues safe. Meet the team and listen in to how they do it.
Teva’s commitment to quality is uncompromising and we manufacture according to the highest quality and compliance standards. This focus is evident at every stage of the development and production of our medicines - from the procurement of raw materials, to the approval of our product submissions by regulatory authorities around the world and commercial distribution.
Our quality and compliance professionals are a key part of the manufacturing process. They play a crucial role in meeting our quality commitments to patients and to the regulatory agencies that approve our medicines.
All of our manufacturing processes are validated and products are tested and certified, using state-of-the-art testing equipment throughout the manufacturing process that ensures adherence to the highest quality and compliance standards.
Teva Global Operations is dedicated to optimising the performance of our global supply chain from the time we procure our first raw materials to the moment our medicines reach patients.
We know that a timely, reliable and cost-effective global distribution capability is critical to providing customers and patients with effective, high-quality products where and when they need them. Our high-volume, technologically-advanced distribution facilities allow us to deliver best-in-class products swiftly and reliably.
Teva has the benefit of being vertically integrated, which means that a major portion of our active pharmaceutical ingredients (APIs) are supplied by our own API manufacturing company, TAPI. That allows us to closely control product quality. But we’re just as strict on our external suppliers, who must meet the same tough requirements we set for ourselves.
As a result, we have an enviable record of Current Good Manufacturing Practice (cGMP) compliance, which is assessed by the US Food and Drug Administration (FDA) and other global regulatory organizations.
A Global Reach
The highest quality medicines wouldn’t be of much use, though, if you couldn’t consistently deliver them when and where they’re needed most. We distribute a staggering number of products – more than 2,400 of them – on time and at a competitive price.
Teva is dedicated to making lives better and healthier. Our unconditional commitment to quality and compliance is fundamental to everything we do.
Back to contents.
Based on 2019 Teva Global Operations internal data.